APLS logo

Apellis Pharmaceuticals, Inc. (APLS)

Profile

Full Name

Apellis Pharmaceuticals, Inc.

Ticker

NASDAQ: APLS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 9, 2017

Indexes

Not included

Website

https://apellis.com

Employees

705

Key Details

Price

$22.95(+2.73%)

Market cap

$2.90B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$781.37M(+97.02% YoY)

Annual EPS

-$1.60(+64.04% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $22.95
    APLS price is $22.95

    30-Day Relative Volume

    1.63
    APLS 30-day relative volume is 1.63

    Price Performance

    Price Most recent change

    +2.73%
    APLS price was up +2.73% on Aug 1, 2025

    Price YTD change

    -28.08%
    APLS price is down -28.08% since January 1st

    Price 1-year change

    -36.25%
    APLS price is down -36.25% year-on-year

    Price 3-year change

    -58.84%
    APLS price is down -58.84% over the past 3 years

    Price Range

    Price All-time high

    $94.75
    APLS price is currently -75.78% below its historical high of $94.75

    Price 3-year low

    $16.10
    APLS price is currently +42.55% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.90B
    APLS market capitalization is $2.90 billion

    Market cap 3-year change

    -52.25%
    APLS market capitalization is down -52.25% over the past 3 years

    Market cap All-time high

    $10.93B
    APLS market capitalization is currently -73.48% below its historical high of $10.93 billion

    Market cap sector rank

    85.47%
    APLS market capitalization is higher than 85.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.71%
    APLS shares outstanding is up +3.71% year-on-year

    Shares Outstanding 3-Year Change

    +16.02%
    APLS shares outstanding is up +16.02% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.90
    APLS beta is 0.90

    200-day SMA

    $24.65
    APLS price is currently -6.88% below its 200-day simple moving average

    50-day SMA

    $18.76
    APLS price is currently +22.36% above its 50-day simple moving average

    RSI

    71.60
    APLS 14-day relative strength index is 71.60

    Volume

    1.63
    APLS 30-day relative volume is 1.63

    ATR

    $1.28
    APLS average true range is $1.28

    10-day Historical Volatility

    94.90%
    APLS 10-day historical volatility is 94.90%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $781.37M
    APLS annual revenue is $781.37 million

    Revenue Analysts estimate

    $903.67M
    APLS annual revenue is currently -13.53% lower than the consensus analysts' forecast

    Revenue 1-year change

    +97.02%
    APLS annual revenue is up +97.02% year-on-year

    Revenue Sector rank

    78.26%
    APLS annual revenue is higher than 78.26% of companies in Healthcare sector

    EPS

    EPS

    -$1.60
    APLS annual earnings per share is -$1.60

    EPS Analysts estimate

    -$0.69
    APLS annual earnings per share is currently +131.21% higher than the consensus analysts' forecast

    EPS 1-year change

    +64.04%
    APLS annual earnings per share is up +64.04% year-on-year

    EPS Sector rank

    44.39%
    APLS annual earnings per share is higher than 44.39% of companies in Healthcare sector

    Profit

    Gross profit

    $663.64M
    APLS annual gross profit is $663.64 million

    Gross margin

    84.93%
    APLS annual gross profit margin is 84.93%

    Operating profit

    -$164.98M
    APLS annual operating income is -$164.98 million

    Operating margin

    -21.11%
    APLS annual operating profit margin is -21.11%

    Net income

    -$197.88M
    APLS annual net profit is -$197.88 million

    Net margin

    -25.32%
    APLS annual net profit margin is -25.32%

    Expenses

    Total expenses

    $946.35M
    APLS annual total expenses is $946.35 million

    Operating expenses

    $828.62M
    APLS annual total operating expenses is $828.62 million

    Cost of goods sold

    $117.72M
    APLS annual cost of goods sold is $117.72 million

    Selling, general & administrative expenses

    $501.05M
    APLS annual SGA is $501.05 million

    Depreciation and amortization

    $1.80M
    APLS annual depreciation & amortization is $1.80 million

    Interest expense

    $40.39M
    APLS annual interest expense is $40.39 million

    Income tax

    $1.16M
    APLS annual income tax is $1.16 million

    EBIT & EBITDA

    EBIT

    -$156.32M
    APLS annual earnings before interest & taxes is -$156.32 million

    EBITDA

    -$154.53M
    APLS annual EBITDA is -$154.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $885.05M
    APLS annual total assets is $885.05 million

    Non current assets

    $96.10M
    APLS annual long term assets is $96.10 million

    Current assets

    $788.95M
    APLS annual total current assets is $788.95 million

    Cash and cash equivalents

    $411.29M
    APLS annual cash & cash equivalents is $411.29 million

    Accounts receivable

    $264.93M
    APLS annual accounts receivable is $264.93 million

    Inventory

    $81.40M
    APLS annual inventory is $81.40 million

    Liabilities

    Total liabilities

    $656.51M
    APLS annual total liabilities is $656.51 million

    Long term liabilities

    $471.00M
    APLS annual total long term liabilities is $471.00 million

    Current liabilities

    $185.51M
    APLS annual total current liabilities is $185.51 million

    Accounts payable

    $38.57M
    APLS annual accounts payable is $38.57 million

    Debt

    Total debt

    $469.78M
    APLS annual total debt is $469.78 million

    Total debt 1-year change

    +323.5%
    APLS annual total debt is up +323.5% year-on-year

    Long term debt

    $463.03M
    APLS annual long term debt is $463.03 million

    Short term debt

    $6.75M
    APLS annual short term debt is $6.75 million

    Equity & Capital

    Shareholders equity

    $228.54M
    APLS annual stockholders equity is $228.54 million

    Book value

    $228.54M
    APLS annual book value is $228.54 million

    Retained earnings

    -$3.04B
    APLS annual retained earnings is -$3.04 billion

    Working capital

    $603.45M
    APLS annual working capital is $603.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$87.87M
    APLS annual cash flow from operations is -$87.87 million

    Cash from operations 1-year change

    +85.23%
    APLS annual cash flow from operations is up +85.23% year-on-year

    Cash from investing

    -$403.00K
    APLS annual cash flow from investing activities is -$403.00 thousand

    Cash from investing 1-year change

    +40.21%
    APLS annual cash flow from investing activities is up +40.21% year-on-year

    Cash from financing

    $149.24M
    APLS annual cash flow from financing activities is $149.24 million

    Cash from financing 1-year change

    -62.17%
    APLS annual cash flow from financing activities is down -62.17% year-on-year

    CAPEX

    CAPEX

    $403.00K
    APLS annual capital expenditures is $403.00 thousand

    CAPEX 1-year change

    -47.87%
    APLS annual capital expenditures is down -47.87% year-on-year

    Free Cash Flow

    Free cash flow

    -$88.27M
    APLS annual free cash flow is -$88.27 million

    Free cash flow 1-year change

    +85.18%
    APLS annual free cash flow is up +85.18% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    84.93%
    APLS annual gross profit margin is 84.93%

    Operating margin

    -21.11%
    APLS annual operating profit margin is -21.11%

    Net margin

    -25.32%
    APLS annual net profit margin is -25.32%

    ROA & ROE

    ROA

    -23.64%
    APLS annual return on assets is -23.64%

    ROE

    -93.55%
    APLS annual return on equity is -93.55%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    APLS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    APLS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    18.54
    APLS price to book ratio is 18.54

    PB ratio Sector rank

    94.69%
    APLS price to book ratio is higher than 94.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.84
    APLS price to sales ratio is 3.84

    PS ratio Sector rank

    56.67%
    APLS price to sales ratio is higher than 56.67% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.00B
    APLS enterprise value is $3.00 billion

    Enterprise value Sector rank

    84.78%
    APLS enterprise value is higher than 84.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -16.80
    APLS EV/EBITDA is -16.80

    EV/EBITDA Sector rank

    8.75%
    APLS EV/EBITDA is higher than 8.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.25
    APLS annual current ratio is 4.25

    Quick ratio

    3.81
    APLS annual quick ratio is 3.81

    Leverage

    Debt to equity

    1.98
    APLS annual debt to equity ratio is 1.98

    Interest coverage ratio

    -3.87
    APLS annual interest coverage ratio is -3.87

    Risk & Stability

    Piotroski F-Score

    5
    APLS piotroski f-score is 5

    Altman Z-Score

    -1.03
    APLS altman z-score is -1.03

    Analyst ratings

    Recent major analysts updates

    Oct 16, 24 William Blair
    Outperform
    Oct 16, 24 Scotiabank
    Sector Perform
    Sep 24, 24 Wells Fargo
    Equal-Weight
    Sep 23, 24 Baird
    Outperform
    Sep 20, 24 Needham
    Buy
    Sep 20, 24 Mizuho
    Neutral
    Sep 13, 24 JP Morgan
    Overweight
    Aug 13, 24 JP Morgan
    Overweight
    Aug 9, 24 Wedbush
    Neutral
    Aug 9, 24 UBS
    Buy

    Institutional Ownership

    Screeners with APLS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Apellis Pharmaceuticals, Inc.?
    • Does Apellis Pharmaceuticals, Inc. pay dividends?
    • What sector is Apellis Pharmaceuticals, Inc. in?
    • What industry is Apellis Pharmaceuticals, Inc. in?
    • What country is Apellis Pharmaceuticals, Inc. based in?
    • When did Apellis Pharmaceuticals, Inc. go public?
    • Is Apellis Pharmaceuticals, Inc. in the S&P 500?
    • Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Apellis Pharmaceuticals, Inc. in the Dow Jones?
    • When was Apellis Pharmaceuticals, Inc.'s last earnings report?
    • When does Apellis Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Apellis Pharmaceuticals, Inc.?

    The ticker symbol for Apellis Pharmaceuticals, Inc. is NASDAQ:APLS

    Does Apellis Pharmaceuticals, Inc. pay dividends?

    No, Apellis Pharmaceuticals, Inc. does not pay dividends

    What sector is Apellis Pharmaceuticals, Inc. in?

    Apellis Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Apellis Pharmaceuticals, Inc. in?

    Apellis Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Apellis Pharmaceuticals, Inc. based in?

    Apellis Pharmaceuticals, Inc. is headquartered in United States

    When did Apellis Pharmaceuticals, Inc. go public?

    Apellis Pharmaceuticals, Inc.'s initial public offering (IPO) was on November 9, 2017

    Is Apellis Pharmaceuticals, Inc. in the S&P 500?

    No, Apellis Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Apellis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Apellis Pharmaceuticals, Inc. in the Dow Jones?

    No, Apellis Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Apellis Pharmaceuticals, Inc.'s last earnings report?

    Apellis Pharmaceuticals, Inc.'s most recent earnings report was on July 31, 2025

    When does Apellis Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Apellis Pharmaceuticals, Inc. is November 5, 2025
    On this page